US Map / Rhode Island
State RI

Clinical Trials in Rhode Island

Rhode Island is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Rhode Island and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 81 actively recruiting studies with Rhode Island sites out of 81 registered in total. The busiest research areas in Rhode Island are Alcohol Use Disorder, Obesity, Acute Stress Disorder. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Rhode Island Hospital. By stage, Rhode Island trials break down as Phase 1 (10), Phase 2 (21), Phase 3 (24), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
81
Recruiting Now
81
← Back to US Map
Top Conditions in Rhode Island
Alcohol Use Disorder (3)Obesity (2)Acute Stress Disorder (2)Healthy (2)Acute Myeloid Leukemia (2)HIV Prevention (2)Stroke (2)Endometrial Cancer (2)Anxiety (2)Recurrent Endometrial Carcinoma (2)Advanced Solid Tumor (2)Anatomic Stage II Breast Cancer AJCC v8 (2)

Frequently Asked Questions — Clinical Trials in Rhode Island

How many clinical trials are currently recruiting in Rhode Island?
ClinicalMetric currently tracks 81 actively recruiting clinical trials with at least one location in Rhode Island. The total number of registered studies—including active but not currently enrolling trials—is 81. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Rhode Island?
Rhode Island hosts clinical trials across a broad range of medical conditions, including Alcohol Use Disorder, Obesity, Acute Stress Disorder, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Rhode Island serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Rhode Island?
To join a clinical trial in Rhode Island, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Rhode Island maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Rhode Island

NCT07036640 N/A
Recruiting
The Impact of Acute Exercise in the Heat on Breast Milk Production and Compositi...
Condition
Lactation
Enrollment
10 pts
Location
United States
Sponsor
Providence College
View Trial →
NCT05799846 N/A
Recruiting
Cognitive Strategies for Weight Loss
Condition
Obesity
Enrollment
360 pts
Location
United States
Sponsor
The Miriam Hospital
View Trial →
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
View Trial →
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
292 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
View Trial →
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years ...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
4,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07713251 N/A
Recruiting
Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills T...
Condition
Alcohol Use Disorder
Enrollment
112 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
590 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
View Trial →
NCT05950464 Phase 1
Recruiting
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the...
Condition
Recurrent Endometrial Carcinoma
Enrollment
65 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06952504 Phase 3
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrol...
Condition
Endometrial Cancer
Enrollment
1,123 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
View Trial →
NCT05235165 Phase 3
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients ...
Condition
Metastatic Malignant Neoplasm in the Lung
Enrollment
62 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06409975 N/A
Recruiting
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and N...
Condition
Healthy
Enrollment
50 pts
Location
United States
Sponsor
University of Rhode Island
View Trial →
NCT02981628 Phase 2
Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma...
Condition
Recurrent B Acute Lymphoblastic Leukemia
Enrollment
80 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT05704712 N/A
Recruiting
Exercise Incentives for YMCA Based Exercise
Condition
Physical Inactivity
Enrollment
330 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT07011563 N/A
Recruiting
Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health
Condition
HIV Prevention
Enrollment
40 pts
Location
United States
Sponsor
Rhode Island Hospital
View Trial →
NCT07284433 Phase 1, Phase 2
Recruiting
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients ...
Condition
Lymphoma Diffuse Large B-cell
Enrollment
178 pts
Location
United States, Germany
Sponsor
AvenCell Therapeutics, Inc.
View Trial →
NCT04968834 N/A
Recruiting
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malign...
Condition
Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT03141021 N/A
Recruiting
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Condition
Malignant Peripheral Nerve Sheath Tumors
Enrollment
1,050 pts
Location
United States, Canada, India
Sponsor
Washington University School o
View Trial →
NCT07192614 Phase 1, Phase 2
Recruiting
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throug...
Condition
Prostate Cancer
Enrollment
52 pts
Location
United States, Belgium, Canada
Sponsor
AstraZeneca
View Trial →
NCT07213804 Phase 3
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum...
Condition
Ovarian Neoplasms
Enrollment
1,630 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
View Trial →
NCT07591922 N/A
Recruiting
Intraoperative Music Therapy in TAVR Patients
Condition
Anxiety
Enrollment
100 pts
Location
United States
Sponsor
Rhode Island Hospital
View Trial →
NCT06465329 Phase 2
Recruiting
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus...
Condition
Non-Small Cell Lung Cancer
Enrollment
120 pts
Location
United States, Brazil, France
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
View Trial →
NCT05180773 Phase 4
Recruiting
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Condition
Peripartum Cardiomyopathy, Postpartum
Enrollment
250 pts
Location
United States
Sponsor
Dennis M. McNamara, MD, MS
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada, Mexico
Sponsor
Canadian Cancer Trials Group
View Trial →
Page 2 of 4 — 81 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology